MetLife Investment Management
ZURA icon

MetLife Investment Management’s Zura Bio ZURA Stock Holding History

MetLife Investment Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+36,749
New +$175K ﹤0.01% 2378
2024
Q4 		– Sell
-27,260
Closed -$111K – 2865
2024
Q3 		$111K Buy
+27,260
New +$102K ﹤0.01% 2584

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

MetLife Investment Management's ZURA Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Zura Bio (ZURA) in Q2 2026: 36,749 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #2378 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in ZURA as recently as Q3 2024.

MetLife Investment Management first reported a position in ZURA in Q3 2024 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • MetLife Investment Management held 36,749 shares of Zura Bio worth $217K as of Q2 2026.
  • Zura Bio was a new MetLife Investment Management position in Q2 2026.
  • Zura Bio made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2378 holding.
  • MetLife Investment Management first reported a position in Zura Bio in Q3 2024 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.